Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Tumor imaging using radiolabelled matrix metalloproteinase-activated anthrax proteins.

Xavier ME, Liu S, Bugge TH, Baguna-Torres J, Mosley M, Hopkins SL, Allen PD, Berridge G, Vendrell I, Fisher R, Kersemans V, Smart S, Leppla SH, Cornelissen B.

J Nucl Med. 2019 Apr 6. pii: jnumed.119.226423. doi: 10.2967/jnumed.119.226423. [Epub ahead of print]

PMID:
30954944
2.

An Activity-Based Probe Targeting Non-Catalytic, Highly Conserved Amino Acid Residues within Bromodomains.

D'Ascenzio M, Pugh KM, Konietzny R, Berridge G, Tallant C, Hashem S, Monteiro O, Thomas JR, Schirle M, Knapp S, Marsden B, Fedorov O, Bountra C, Kessler BM, Brennan PE.

Angew Chem Int Ed Engl. 2019 Jan 21;58(4):1007-1012. doi: 10.1002/anie.201807825. Epub 2018 Dec 27.

3.

BRAF/MAPK and GSK3 signaling converges to control MITF nuclear export.

Ngeow KC, Friedrichsen HJ, Li L, Zeng Z, Andrews S, Volpon L, Brunsdon H, Berridge G, Picaud S, Fischer R, Lisle R, Knapp S, Filippakopoulos P, Knowles H, Steingrímsson E, Borden KLB, Patton EE, Goding CR.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8668-E8677. doi: 10.1073/pnas.1810498115. Epub 2018 Aug 27.

4.

Glutamate receptor δ2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome.

Berridge G, Menassa DA, Moloney T, Waters PJ, Welding I, Thomsen S, Zuberi S, Fischer R, Aricescu AR, Pike M, Dale RC, Kessler B, Vincent A, Lim M, Irani SR, Lang B.

Neurology. 2018 Aug 21;91(8):e714-e723. doi: 10.1212/WNL.0000000000006035. Epub 2018 Jul 25.

5.

A TFEB nuclear export signal integrates amino acid supply and glucose availability.

Li L, Friedrichsen HJ, Andrews S, Picaud S, Volpon L, Ngeow K, Berridge G, Fischer R, Borden KLB, Filippakopoulos P, Goding CR.

Nat Commun. 2018 Jul 11;9(1):2685. doi: 10.1038/s41467-018-04849-7.

6.

CDA directs metabolism of epigenetic nucleosides revealing a therapeutic window in cancer.

Zauri M, Berridge G, Thézénas ML, Pugh KM, Goldin R, Kessler BM, Kriaucionis S.

Nature. 2015 Aug 6;524(7563):114-8. doi: 10.1038/nature14948. Epub 2015 Jul 22.

7.

Structures of ABCB10, a human ATP-binding cassette transporter in apo- and nucleotide-bound states.

Shintre CA, Pike AC, Li Q, Kim JI, Barr AJ, Goubin S, Shrestha L, Yang J, Berridge G, Ross J, Stansfeld PJ, Sansom MS, Edwards AM, Bountra C, Marsden BD, von Delft F, Bullock AN, Gileadi O, Burgess-Brown NA, Carpenter EP.

Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9710-5. doi: 10.1073/pnas.1217042110. Epub 2013 May 28.

8.

The structural basis of ZMPSTE24-dependent laminopathies.

Quigley A, Dong YY, Pike AC, Dong L, Shrestha L, Berridge G, Stansfeld PJ, Sansom MS, Edwards AM, Bountra C, von Delft F, Bullock AN, Burgess-Brown NA, Carpenter EP.

Science. 2013 Mar 29;339(6127):1604-7. doi: 10.1126/science.1231513.

PMID:
23539603
9.

The PHD and chromo domains regulate the ATPase activity of the human chromatin remodeler CHD4.

Watson AA, Mahajan P, Mertens HD, Deery MJ, Zhang W, Pham P, Du X, Bartke T, Zhang W, Edlich C, Berridge G, Chen Y, Burgess-Brown NA, Kouzarides T, Wiechens N, Owen-Hughes T, Svergun DI, Gileadi O, Laue ED.

J Mol Biol. 2012 Sep 7;422(1):3-17. doi: 10.1016/j.jmb.2012.04.031. Epub 2012 May 7.

10.

Conformational plasticity of glycogenin and its maltosaccharide substrate during glycogen biogenesis.

Chaikuad A, Froese DS, Berridge G, von Delft F, Oppermann U, Yue WW.

Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21028-33. doi: 10.1073/pnas.1113921108. Epub 2011 Dec 12.

11.

Expressing the human proteome for affinity proteomics: optimising expression of soluble protein domains and in vivo biotinylation.

Keates T, Cooper CD, Savitsky P, Allerston CK, Phillips C, Hammarström M, Daga N, Berridge G, Mahajan P, Burgess-Brown NA, Müller S, Gräslund S, Gileadi O.

N Biotechnol. 2012 Jun 15;29(5):515-25. doi: 10.1016/j.nbt.2011.10.007. Epub 2011 Oct 19.

12.

High-performance liquid chromatography separation and intact mass analysis of detergent-solubilized integral membrane proteins.

Berridge G, Chalk R, D'Avanzo N, Dong L, Doyle D, Kim JI, Xia X, Burgess-Brown N, Deriso A, Carpenter EP, Gileadi O.

Anal Biochem. 2011 Mar 15;410(2):272-80. doi: 10.1016/j.ab.2010.11.008. Epub 2010 Nov 17.

13.

Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration.

Grundler R, Brault L, Gasser C, Bullock AN, Dechow T, Woetzel S, Pogacic V, Villa A, Ehret S, Berridge G, Spoo A, Dierks C, Biondi A, Knapp S, Duyster J, Schwaller J.

J Exp Med. 2009 Aug 31;206(9):1957-70. doi: 10.1084/jem.20082074. Epub 2009 Aug 17.

14.

Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers.

Muirhead CR, O'Hagan JA, Haylock RG, Phillipson MA, Willcock T, Berridge GL, Zhang W.

Br J Cancer. 2009 Jan 13;100(1):206-12. doi: 10.1038/sj.bjc.6604825.

15.

High throughput production of recombinant human proteins for crystallography.

Gileadi O, Burgess-Brown NA, Colebrook SM, Berridge G, Savitsky P, Smee CE, Loppnau P, Johansson C, Salah E, Pantic NH.

Methods Mol Biol. 2008;426:221-46. doi: 10.1007/978-1-60327-058-8_14.

PMID:
18542867
16.

Structure of PICK1 and other PDZ domains obtained with the help of self-binding C-terminal extensions.

Elkins JM, Papagrigoriou E, Berridge G, Yang X, Phillips C, Gileadi C, Savitsky P, Doyle DA.

Protein Sci. 2007 Apr;16(4):683-94.

17.

Cell-permeant small-molecule modulators of NAADP-mediated Ca2+ release.

Dowden J, Berridge G, Moreau C, Yamasaki M, Churchill GC, Potter BV, Galione A.

Chem Biol. 2006 Jun;13(6):659-65.

18.

Epidemiological studies of UK test veterans: II. Mortality and cancer incidence.

Muirhead CR, Kendall GM, Darby SC, Doll R, Haylock RG, O'Hagan JA, Berridge GL, Phillipson MA, Hunter N.

J Radiol Prot. 2004 Sep;24(3):219-41. Review.

PMID:
15511015
19.

Chemical synthesis of the second messenger nicotinic acid adenine dinucleotide phosphate by total synthesis of nicotinamide adenine dinucleotide phosphate.

Dowden J, Moreau C, Brown RS, Berridge G, Galione A, Potter BV.

Angew Chem Int Ed Engl. 2004 Sep 6;43(35):4637-40. No abstract available.

PMID:
15352191
20.

Definition of the domain boundaries is critical to the expression of the nucleotide-binding domains of P-glycoprotein.

Kerr ID, Berridge G, Linton KJ, Higgins CF, Callaghan R.

Eur Biophys J. 2003 Nov;32(7):644-54. Epub 2003 Jun 26.

PMID:
12830334
21.
22.

Follow up of mortality and incidence of cancer 1952-98 in men from the UK who participated in the UK's atmospheric nuclear weapon tests and experimental programmes.

Muirhead CR, Bingham D, Haylock RG, O'Hagan JA, Goodill AA, Berridge GL, English MA, Hunter N, Kendall GM.

Occup Environ Med. 2003 Mar;60(3):165-72.

23.

Solubilization of receptors for the novel Ca2+-mobilizing messenger, nicotinic acid adenine dinucleotide phosphate.

Berridge G, Dickinson G, Parrington J, Galione A, Patel S.

J Biol Chem. 2002 Nov 15;277(46):43717-23. Epub 2002 Sep 9.

24.
25.

The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influence.

Rothnie A, Theron D, Soceneantu L, Martin C, Traikia M, Berridge G, Higgins CF, Devaux PF, Callaghan R.

Eur Biophys J. 2001 Oct;30(6):430-42.

PMID:
11718296
26.

Repacking of the transmembrane domains of P-glycoprotein during the transport ATPase cycle.

Rosenberg MF, Velarde G, Ford RC, Martin C, Berridge G, Kerr ID, Callaghan R, Schmidlin A, Wooding C, Linton KJ, Higgins CF.

EMBO J. 2001 Oct 15;20(20):5615-25.

27.

Drug binding sites on P-glycoprotein are altered by ATP binding prior to nucleotide hydrolysis.

Martin C, Berridge G, Mistry P, Higgins C, Charlton P, Callaghan R.

Biochemistry. 2000 Oct 3;39(39):11901-6.

PMID:
11009602
28.

Communication between multiple drug binding sites on P-glycoprotein.

Martin C, Berridge G, Higgins CF, Mistry P, Charlton P, Callaghan R.

Mol Pharmacol. 2000 Sep;58(3):624-32.

PMID:
10953057
29.

The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein.

Martin C, Berridge G, Mistry P, Higgins C, Charlton P, Callaghan R.

Br J Pharmacol. 1999 Sep;128(2):403-11.

30.

Occupational radiation exposure and mortality: second analysis of the National Registry for Radiation Workers.

Muirhead CR, Goodill AA, Haylock RG, Vokes J, Little MP, Jackson DA, O'Hagan JA, Thomas JM, Kendall GM, Silk TJ, Bingham D, Berridge GL.

J Radiol Prot. 1999 Mar;19(1):3-26.

PMID:
10321692
31.

A randomised controlled trial of care of the perineum during second stage of normal labour.

McCandlish R, Bowler U, van Asten H, Berridge G, Winter C, Sames L, Garcia J, Renfrew M, Elbourne D.

Br J Obstet Gynaecol. 1998 Dec;105(12):1262-72.

PMID:
9883917
32.
33.

The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface.

Callaghan R, Berridge G, Ferry DR, Higgins CF.

Biochim Biophys Acta. 1997 Sep 4;1328(2):109-24.

34.

Labour and birth in water in England and Wales.

Alderdice F, Renfrew M, Marchant S, Ashurst H, Hughes P, Berridge G, Garcia J.

BMJ. 1995 Apr 1;310(6983):837. No abstract available.

35.

The chromatin-associated protein H-NS.

Ussery DW, Hinton JC, Jordi BJ, Granum PE, Seirafi A, Stephen RJ, Tupper AE, Berridge G, Sidebotham JM, Higgins CF.

Biochimie. 1994;76(10-11):968-80.

PMID:
7748941
36.

Ideal house for the district nurse.

BERRIDGE G.

Nurs Mirror Midwives J. 1945 Dec 15;82:173. No abstract available.

PMID:
21007759

Supplemental Content

Loading ...
Support Center